It is worth noting that 11 different PD-L1 antibodies have been utilized in IHC, and each PD-L1 antibody showed distinct PD-L1 expression and subcellular distribution pattern in glioma cells, indicating the intriguing role of PD-L1 in glioma. The gene discussed is CD274; the disease is central nervous system cancer.